NCT00674141撤回1 期
Nasal Administration of Dexamethasone for MS Treatment
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- reduction in the EDSS functional system score
研究概览
简要总结
The study aims to assess the safety and efficacy of nasale administration of Dexamethasone in relapsing MS patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •MS patients with esatblished relapsing remitting attacks
- •increase in EDSS of at least 1 point for a least one day
排除标准
- •children under 18
- •pregnant patients
- •patients with diabetes
- •known allergy to steroids
- •patients who received steroids within 3 months prior to the study
研究组 & 干预措施
1
Other
only one experimental treated group
干预措施: Dexamethasone soduim phosphate (Drug)
结局指标
主要结局
reduction in the EDSS functional system score
时间窗: four months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19Covid19NCT04513184Edda Sciutto Conde66
已完成
3 期
Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)Macular EdemaNCT01660802Allergan262
已完成
1 期
Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior UveitisNon-Infectious Anterior UveitisNCT02309385Aciont Inc44
已完成
1 期
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein OcclusionMacular EdemaBranch Retinal Vein OcclusionMacular DegenerationNCT00308477Sanwa Kagaku Kenkyusho Co., Ltd.
已完成
3 期
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular EdemaDiabetic Macular EdemaNCT00168337Allergan554